glp 1 agonist addiction GLP-1 Receptor Agonists in Treatment: The Next Big Thing or Just Hype? Frontiers | The therapeutic potential
Description
Endogenous hyperinsulinemia may cause weight gain and obesity [30], and treatment with insulin causes substantial weight gain, and may even increase cardiovascular risk [31]
[FDA.gov] Medical Disclaimer This article is for informational and educational purposes only and does not constitute medical advice
Patients who develop symptoms of pancreatitis (e.g., upper abdominal pain radiating to the back, nausea, vomiting) should be evaluated promptly, and tirzepatide should be discontinued if pancreatitis is confirmed
Triggs EJ, Johnson JM, Learoyd B
Being aware of these risks is important
